Oculomics is indeed rapidly entering healthcare and the prediction of various diseases. In that LinkedIn post related to the AHA2026 event, there are links to a couple of good articles regarding retinal imaging and cardiovascular diseases.
At least the first publication mentions Optomed: “non-financial support from Optomed” and “Aaron Lee reports a relationship with Optomed Oyj that includes: non-financial support”